Research indicates that while the most severe effects of SARS-CoV-2 were observed in patients with acute COVID-19, individuals who experienced milder cases and were not hospitalized also reported symptoms of memory loss and attention deficits lasting over 18 months post-infection.
Memory loss and attention deficit are common complaints among severe COVID-19 survivors. However, these and other cognitive impairments have also been observed in patients with mild cases more than 18 months after infection, according to a study by researchers at the University of São Paulo (USP) in Brazil.
An article on the study is published in the journal BMC Psychology. The findings highlight the need for more comprehensive rehabilitation to address the enduring cognitive impacts of long COVID, the authors write.
Data collected from 302 volunteers pointed to cognitive impairment in 11.7% of mild patients, 39.2% of moderate patients, and 48.9% of severe patients.
"Although the damage done by the disease in terms of memory loss, attention deficit, and slow processing increases in proportion to its severity, the same problems affect a far from a negligible number of people – around 100 in our study – who had mild or moderate COVID," said Antônio de Pádua Serafim, first author of the article and a professor at the Institute of Psychology (IP-USP).
The results of the study, which was funded by FAPESP, evidence the potential impact of neuroinflammation due to infection by SARS-CoV-2.
"Memory loss and attention deficit are known to be associated with post-intensive care syndrome due to intubation under deep anesthesia. Some of the data analyzed in the study, however, was from patients who didn't require intensive care or didn't even have sufficient symptoms to be hospitalized and nevertheless exhibited memory loss and attention deficit. The findings therefore opened our eyes to the question of neuroinflammation due to COVID-19," Serafim said.
Memory and attention are important cognitive functions that affect people's day-to-day lives. Reflecting this, participants in the study with poor memory and attention test scores reported difficulties with recalling words or performing routine activities, such as forgetting pots on the stove or failing to pick children up from school.
"Hierarchically speaking, attention is the primary function in all mental activity, and this explains why attention deficit has such as huge impact on people's daily lives. High-quality attention is required to think and act in various ways at the same time. Impairment of attention in turn affects memory. In some cases, attentional activity is so dispersed that each new stimulus [or impending activity] dissolves, so that the person can't remember what they were doing. This also affects processing activity, which involves rapid decision-making based on information," he said.
Cognitive rehabilitation
According to Serafim, all the evidence has shown for some time that SARS-CoV-2 can affect the central nervous system as well as the lungs, kidneys, heart, and muscles, but the extent of the damage it may cause is poorly understood. "We don't know if cognitive impairment due to COVID-19 is permanent, and we're currently evaluating ways to intervene in this process," he said.
In partnership with other researchers at USP, Serafim is developing programs to try to mitigate the cognitive losses caused by COVID-19. The aim is to find out whether techniques such as neurostimulation and neurofeedback can attenuate or reserve memory loss and attention deficit.
"Both are non-invasive techniques that aim to improve brain functions by means of neuromodulation, which can stimulate the connections among neurons in the brain [synapses]. We have only case studies so far. For example, in the case of a physician who was in the intensive care unit for 34 days, we conducted a neurofeedback protocol often used to study patients with attention deficit disorder, and he made a good recovery. But that was an isolated case," he said.
"Based on the knowledge we've acquired so far regarding cognitive stimulation and rehabilitation techniques, I believe it may be possible to obtain an improvement in neural connectivity by means of brain training to stimulate overall cognitive ability. The severe phase of the pandemic is over, but the sequelae persist. So it's not a closed case. Many people were infected, and many have sequelae of this kind. However, we don't have an effective program to intervene not only in the emotional aspects but also in the cognitive difficulties resulting from COVID-19."
Reference: "Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations" by Antonio de Pádua Serafim, Fabiana Saffi, Amanda Rafaella A. Soares, Alessandra Mara Morita, Mariana Medeiros Assed, Sandro de Toledo, Cristiana C. A. Rocca and Ricardo S. S. Durães, 26 April 2024, BMC Psychology.
DOI: 10.1186/s40359-024-01740-7
The study was funded by the São Paulo Research Foundation.
News
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
Biomedical researchers at Texas A&M University may have discovered a way to stop or even reverse the decline of cellular energy production—a finding that could have revolutionary effects across medicine. Dr. Akhilesh K. Gaharwar [...]
The Stunning New Push to Protect the Invisible 99% of Life
Scientists worldwide have joined forces to build the first-ever roadmap for conserving Earth’s vast invisible majority—microbes. Their new IUCN Specialist Group reframes conservation by elevating microbial life to the same urgency as plants and [...]
Scientists Find a Way to Help the Brain Clear Alzheimer’s Plaques Naturally
Scientists have discovered that the brain may have a built-in way to fight Alzheimer’s. By activating a protein called Sox9, researchers were able to switch on star-shaped brain cells known as astrocytes and turn them into [...]
Vision can be rebooted in adults with amblyopia, study suggests
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows. In the common vision [...]
Ultrasound-activated Nanoparticles Kill Liver Cancer and Activate Immune System
A new ultrasound-guided nanotherapy wipes out liver tumors while training the immune system to keep them from coming back. The study, published in Nano Today, introduces a biodegradable nanoparticle system that combines sonodynamic therapy and cell [...]
Magnetic nanoparticles that successfully navigate complex blood vessels may be ready for clinical trials
Every year, 12 million people worldwide suffer a stroke; many die or are permanently impaired. Currently, drugs are administered to dissolve the thrombus that blocks the blood vessel. These drugs spread throughout the entire [...]
Reviving Exhausted T Cells Sparks Powerful Cancer Tumor Elimination
Scientists have discovered how tumors secretly drain the energy from T cells—the immune system’s main cancer fighters—and how blocking that process can bring them back to life. The team found that cancer cells use [...]
Very low LDL-cholesterol correlates to fewer heart problems after stroke
Brigham and Women's Hospital's TIMI Study Group reports that in patients with prior ischemic stroke, very low achieved LDL-cholesterol correlated with fewer major adverse cardiovascular events and fewer recurrent strokes, without an apparent increase [...]
“Great Unified Microscope” Reveals Hidden Micro and Nano Worlds Inside Living Cells
University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light at once, letting scientists see everything from large cell structures to tiny nanoscale particles in a single shot. Researchers [...]
Breakthrough Alzheimer’s Drug Has a Hidden Problem
Researchers in Japan found that although the Alzheimer’s drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain’s waste-clearing system within the first few months of treatment. The study suggests that [...]
